Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Veridex, a J&J Company, Gains OK for Cancer IVD Test in China

publication date: Dec 13, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Veridex, a Johnson & Johnson company, received SFDA approval for CellSearch, an in vitro diagnostic device that tests for circulating tumor cells (CTC) in the bloodstream. The initial indication is women with metastatic breast cancer. In 2004, CellSearch was first approved in the US, also for metastatic breast cancer. Subsequently, it added indications for metastatic colon cancer and metastatic prostate cancer. More details....

Stock Symbol: (NYSE: JNJ)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
Shanghai, China
April 14-15, 2015

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors